Larimar Therapeutics Inc
(LRMR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,097 | 71,525 | 70,630 | 62,193 | 68,148 |
| Marketable Securities | N/A | 6,499 | N/A | 19,245 | 24,490 |
| TOTAL | $72,204 | $81,253 | $74,036 | $86,127 | $97,952 |
| Non-Current Assets | |||||
| PPE Net | 1,049 | 1,135 | 1,211 | 998 | 1,040 |
| Other Non-Current Assets | 5,414 | 5,550 | 5,684 | 5,894 | 5,694 |
| TOTAL | $6,463 | $6,685 | $6,895 | $6,892 | $6,734 |
| Total Assets | $78,667 | $87,938 | $80,931 | $93,019 | $104,686 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,660 | 1,766 | 1,463 | 3,230 | 2,634 |
| Accrued Expenses | 6,592 | 7,966 | 5,675 | 4,611 | 5,843 |
| TOTAL | $8,846 | $10,306 | $7,691 | $8,375 | $8,992 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,408 | 5,565 | 5,715 | 5,860 | 6,002 |
| TOTAL | $5,408 | $5,565 | $5,715 | $5,860 | $6,002 |
| Total Liabilities | $14,254 | $15,871 | $13,406 | $14,235 | $14,994 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,710 | 17,710 | 17,710 | 15,368 | 15,368 |
| Common Shares | 18 | 18 | 15 | 15 | 15 |
| Retained earnings | -116,250 | -107,116 | -90,311 | -77,702 | -65,614 |
| Other shareholders' equity | 0 | 0 | 1 | 1 | 1 |
| TOTAL | $64,413 | $72,067 | $67,525 | $78,784 | $89,692 |
| Total Liabilities And Equity | $78,667 | $87,938 | $80,931 | $93,019 | $104,686 |